Cigarette smoke-induced pulmonary inflammation is attenuated in CD69-deficient mice

Reference

• Ziegler SF, Ramsdell F, Hjerrild KA, Armitage RJ, Grabstein KH, Hennen KB, Farrah T, Fanslow WC, Shevach EM, Alderson MR. Molecular characterization of the early activation antigen CD69: A type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur J Immunol 1993, 23, 1643–1648.
   PubMed Web of Science ®Google Scholar
• Testi R, D’Ambrosio D, De Maria R, Santoni A. The CD69 receptor: A multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994, 15, 479–483.
   PubMedGoogle Scholar
• Lanier LL, Buck DW, Rhodes L, Ding A, Evans E, Barney C, Phillips JH. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 1988, 167, 1572–1585.
   PubMed Web of Science ®Google Scholar
• Atzeni F, Schena M, Ongari AM, Carrabba M, Bonara P, Minonzio F, Capsoni F. Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-α. Cell Immunol 2002, 220, 20–29.
   Google Scholar
• Marzio R, Jirillo E, Ransijn A, Mauël J, Corradin SB. Expression and function of the early activation antigen CD69 in murine macrophages. J Leukoc Biol 1997, 62, 349–355.
   PubMed Web of Science ®Google Scholar
• Julius P, Luttmann W, Knoechel B, Kroegel C, Matthys H, Virchow JC Jr. CD69 surface expression on human lung eosinophils after segmental allergen provocation. Eur Respir J 1999, 13, 1253–1259.
   Google Scholar
• Murata K, Inami M, Hasegawa A, Kubo S, Kimura M, Yamashita M, Hosokawa H, Nagao T, Suzuki K, Hashimoto K, Shinkai H, Koseki H, Taniguchi M, Ziegler SF, Nakayama T. CD69-null mice protected from arthritis induced with anti-type II collagen antibodies. Int Immunol 2003, 15, 987–992.
   PubMed Web of Science ®Google Scholar
• Miki-Hosokawa T, Hasegawa A, Iwamura C, Shinoda K, Tofukuji S, Watanabe Y, Hosokawa H, Motohashi S, Hashimoto K, Shirai M, Yamashita M, Nakayama T. CD69 controls the pathogenesis of allergic airway inflammation. J Immunol 2009, 183, 8203–8215.
   PubMed Web of Science ®Google Scholar
• Marzio R, Mauël J, Betz-Corradin S. CD69 and regulation of the immune function. Immunopharmacol Immunotoxicol 1999, 21, 565–582.
   PubMed Web of Science ®Google Scholar
• Freeman CM, Han MK, Martinez FJ, Murray S, Liu LX, Chensue SW, Polak TJ, Sonstein J, Todt JC, Ames TM, Arenberg DA, Meldrum CA, Getty C, McCloskey L, Curtis JL. Cytotoxic potential of lung CD8+ T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol 2010, 184, 6504–6513.
   PubMed Web of Science ®Google Scholar
• Yao H, Yang SR, Edirisinghe I, Rajendrasozhan S, Caito S, Adenuga D, O’Reilly MA, Rahman I. Disruption of p21 attenuates lung inflammation induced by cigarette smoke, LPS, and fMLP in mice. Am J Respir Cell Mol Biol 2008, 39, 7–18.
   PubMed Web of Science ®Google Scholar
• Vlahos R, Bozinovski S, Chan SP, Ivanov S, Lindén A, Hamilton JA, Anderson GP. Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am J Respir Crit Care Med 2010, 182, 34–40.
   PubMed Web of Science ®Google Scholar
• Churg A, Dai J, Tai H, Xie C, Wright JL. Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med 2002, 166, 849–854.
   PubMed Web of Science ®Google Scholar
• Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factor-α drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004, 170, 492–498.
   PubMed Web of Science ®Google Scholar
• Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur J Haematol 1995, 54, 1–8.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD 2004, 1, 59–70.
   PubMedGoogle Scholar
• Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999, 115, 829–835.
   PubMed Web of Science ®Google Scholar
• D’hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir Res 2005, 6, 147.
   PubMedGoogle Scholar
• Hirama N, Shibata Y, Otake K, Machiya J, Wada T, Inoue S, Abe S, Takabatake N, Sata M, Kubota I. Increased surfactant protein-D and foamy macrophages in smoking-induced mouse emphysema. Respirology 2007, 12, 191–201.
   PubMed Web of Science ®Google Scholar
• Carter CA, Misra M. Effects of short-term cigarette smoke exposure on Fischer 344 rats and on selected lung proteins. Toxicol Pathol 2010, 38, 402–415.
   Google Scholar
• Morris A, Kinnear G, Wan WY, Wyss D, Bahra P, Stevenson CS. Comparison of cigarette smoke-induced acute inflammation in multiple strains of mice and the effect of a matrix metalloproteinase inhibitor on these responses. J Pharmacol Exp Ther 2008, 327, 851–862.
   PubMedGoogle Scholar
• McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 1997, 3, 189–195.
   PubMed Web of Science ®Google Scholar